A Planned Study at Multiple Sites is Being Done to Compare the Results of Two Types of Trifocal Toric Intraocular Lenses Used in Cataract Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorBiotech Healthcare Holding Gmbh

About this trial

To evaluate the clinical outcomes and patient satisfaction of two commercially available trifocal toric intraocular lenses Primary Objective: To compare the distance-corrected intermediate visual acuity between the two trifocal toric intraocular lenses. Secondary Objectives: To assess and compare the safety of two trifocal toric intraocular lenses.

Eligibility criteria

Qualifiers

Age of patient >21 Years

Patient diagnosed with cataract.

Patient must have preoperative regular corneal astigmatism between 0.75 to 4.5 D as per corneal topography or keratometry

Calculated IOL power is within the range of investigational IOLs.

Disqualifiers

Previous intraocular or corneal surgery.

Traumatic cataract

Pregnancy (as stated by patient) or lactation.

Concurrent participation in another drug or device investigation.

Trial design

Treatments tested in this trial

  • Optiflex TRIO Intraocular Lens
  • AcrySof® IQ PanOptix®

Treatment groups

138 Participants
are divided into 2 treatment groups